AUSTRALIAN CLINICAL - Key Persons
Job Titles:
- Independent Non - Executive Director
- Non - Executive Director
- Chairman of Nexus Hospitals
- Independent Non - Executive Director Read More
- Professor
Dr Leanne Rowe has been a Non-Executive Director of ACL since 28 April 2021.
Leanne is a clinical professor and medical practitioner with over 30 years of clinical experience in the public and private health systems across acute care, aged care, mental health and community health.
Leanne is currently Chair of Nexus Hospitals and a Presiding Member for Medical Panels Victoria. She has previously served on a wide range of boards as a Non-Executive Director including Japara Healthcare Limited, Medibank Private Limited, I-MED Radiology Network, the Medical Indemnity Protection Society, the Royal Australian College of General Practitioners, Barwon Health and beyondblue.
Leanne is a former Deputy Chancellor of Monash University and has been awarded a Doctor of Laws (Honoris Causa) for her services. Leanne has also received a Member of the Order of Australia for her services to medicine. Her other qualifications include a Doctor of Medicine, Bachelor of Medicine Degree and Bachelor of Surgery Degree, Fellowship of the Royal Australian College of General Practitioners and Fellowship of the Australian Institute of Company Directors.
Mr Michael Alscher has over 30 years' experience of investing and working as a strategy consultant within the healthcare sector. Michael was appointed Chair of ACL's predecessor corporate vehicle, Clinical Laboratories Pty Ltd in 2015, following its acquisition by Crescent Capital Partners in 2015. Michael was appointed a Director of ACL on 19 December 2020 and Chair of ACL as part of the IPO process on 19 December 2020.
Michael is the Managing Partner and founder of Crescent Capital Partners, a leading Australian private equity investment firm, specialising in high growth companies and certain industry sectors such as healthcare where Crescent Capital Partners is the largest private equity investor (by number of investments) in healthcare in Australia.
Through Cresent Capital Partners, Michael has been investing in healthcare for over 18 years and has worked in healthcare as a strategy consultant prior to this period since 1992.
Michael is the current Chair of Cardno Limited, National Dental Care Pty Limited, 24-7 Healthcare Pty Ltd, Emapta Holdco Pte Ltd and Green Leaves Early Learning Centres Pty Ltd and is a Non-Executive Director of Clearview Wealth Limited and Aurora Expeditions Holdings Pty Ltd. Michael's former director roles include Chair of Cover-More Group Limited and LifeHealthcare Group Limited and Director of Metro Performance Glass Limited, Intega Group Limited and National Hearing Care Pty Ltd.
Job Titles:
- Chairman of Land Registry Services
- Independent Non - Executive Director & Chair of the Remuneration and Nomination Committee Read More
- Non - Executive Director of ACL
Mr Andrew Dutton has been a Non-Executive Director of ACL since 28 April 2021. Andrew has 30 years of management, business development and technology experience across Australia, Asia and Europe.
Andrew is the current Chair of Land Registry Services and was recently an advisor to Financial Force APJ. He has had extensive CEO and Board experience globally and within Australia.
Andrew's former roles include Chair of NVOI Pty Ltd and SAI Global Pty Ltd, CEO at Land Registry Services and Integrated Research Limited and Managing Director of the Asia Pacific/Japan region for VMware Inc. He has also held senior executive positions at IBM, Computer Associates, BEA Systems Inc., Lendlease and Norwich Union Financial Services Group, including roles as CFO, CMO, CRO and Divisional Heads. At IBM, Andrew was elected to the Worldwide Senior Leadership Team.
Andrew holds a Bachelor of Science Degree from the University of Sydney and is a member of the Australian Institute of Company Directors.
Job Titles:
- Non - Executive Director
- Independent Non - Executive Director & Chair of the Audit and Risk Committee Read More
- Lead Independent Director and Chair of the Audit and Risk Committee of Abacus Property Group
Mr Mark Haberlin has been a Non-Executive Director of ACL since 28 April 2021.
Mark has over 25 years of audit, risk management, capital transactions and mergers and acquisitions experience across industries including healthcare, real estate and financial services.
Mark is the Lead Independent Director and Chair of the Audit and Risk Committee of Abacus Property Group. Mark is also an Independent Non-Executive Director and the Chair of the Audit and Risk Committee of Laybuy Group Limited. Previously, Mark was the Chair of PwC Australia and PwC's Public Reporting Panel, as well as a Director of the European Australia Business Council and PwC Asia Pacific.
Mark holds a Bachelor of Science (Civil Engineering) (Honours) from Imperial College London and qualified as a Chartered Accountant in the United Kingdom.
Job Titles:
- Non - Executive Director
- Non - Executive Director of ACL
- Non - Executive Director Read More
Mr Nathanial Thomson has been a Non-Executive Director of ACL's predecessor corporate vehicle, Clinical Laboratories Pty Ltd, since April 2018. Nathanial was reappointed a Non-Executive Director of ACL on 19 December 2020.
Nathanial is a Partner at Crescent Capital Partners, a leading Australian private equity investment firm. Nathanial has over 20 years of experience in strategy consulting, private equity and investment banking and over 19 years experience investing and consulting into the healthcare sector. Prior to joining Crescent Capital Partners, Nathanial worked as a consultant at McKinsey & Co.
Nathanial is the current Chair of Clover Insurance, Executive Director of Cardno Limited and Non-Executive Director of National Dental Care Limited, Clearview Wealth Limited and 24-7 Healthcare Pty Ltd. Nathanial's former director roles include Deputy Chair of Cover-More Group Limited and Non-Executive Director of Metro Performance Glass Limited.
Nathanial holds a Bachelor of Commerce Degree and Bachelor of Laws Degree from the University of Western Australia.
Job Titles:
- Independent Non - Executive Director
- Non - Executive Director
- Independent Non - Executive Director Read More
- Member of the UNSW Australian School
- Non - Executive Director of Mirvac Limited
Ms Christine Bartlett was appointed as a Non-Executive Director on 23 August 2023. Christine is an experienced non-executive director, with extensive executive experience gained through chief executive officer and senior executive roles with National Australia Bank Limited, IBM and Jones Lang LaSalle. Christine has held roles with national and global responsibilities and has a strong commercial perspective, particularly in fostering innovation and leveraging new emerging technologies.
Christine is currently a non-executive director of Mirvac Limited, Sigma Healthcare Limited, TAL Life Limited and Reliance Worldwide Corporation Limited.
Christine is a member of the UNSW Australian School of Business Advisory Council, Chief Executive Women and the Australian Institute of Company Directors. Christine holds a Bachelor of Science from the University of Sydney and has completed senior executive management programs at INSEAD.
Christine has previously held non-executive director roles with iCare NSW, Clayton Utz, GBST Holdings Limited and The Smith Family.
Job Titles:
- Chief Executive Officer
- Executive Director
- Chief Executive Officer and Executive Director of ACL
- Chief Executive Officer and Executive Director Read More
Ms Melinda McGrath has been the Chief Executive Officer and Executive Director of ACL's predecessor corporate vehicle, Clinical Laboratories Pty Ltd since 2015. Melinda was reappointed an Executive Director of ACL on 19 December 2020. Melinda has more than 30 years' experience in healthcare, with over 25 years of experience in chief executive roles and over 15 years of experience in pathology CEO roles.
Melinda has designed and led the organisation's restructure and transformation, building ACL's scale and driving operational performance improvement while overseeing the integration of Healthscope's Australian pathology business, SJGHC's pathology business, Perth Pathology, SunDoctors and Medlab. She has also driven the establishment of one performance-oriented culture across the organisation achieve cultural alignment and deliver one unified integrated pathology system.
Melinda was CEO of QML Pathology (part of Healius (formerly Primary Health Care) from 2008 to 2015, where she developed five QML brands as well as establised Tasmania Medical Laboratories. Prior to that, Melinda held various transformative chief executive roles at private regional and tertiary referral hospitals in Queensland including St Andrew's War Memorial Hospital, The Sunshine Coast Private Hospital and St Stephens Private Hospital.
Melinda has held directorships at Metro North Hospitals and Health Service including Royal Brisbane, Prince Charles, Redcliffe, Caboolture and related health services, Geneseq Biosciences and a superannuation fund, UC Super. Melinda is a Director of Australian Pathology.
Melinda holds a Bachelor of Human Movement Studies Degree and a Bachelor of Arts Degree from the University of Queensland, a Master of Business Administration from the University of Central Queensland, and a Certificate in Governance Practice from the Governance Institute of Australia.